Beneficial approaches for controlling brucellosis include surveillance through serologic testing, vaccination, quarantine of infected animals, sanitation practices, and control of animal movement. Effective vaccination requires a coordinated control program involving testing, record keeping, and removal of infected animals. While no vaccine can completely prevent infection, approved vaccines can significantly reduce transmission and disease in livestock.

1. Beneficial Approaches forBeneficial Approaches for
Controlling BrucellosisControlling Brucellosis
Dr. Steven Olsen
National Animal Disease Center
Ames, IA 50010
Workshop: An Integrated Approach to
Controlling Brucellosis in Africa, Addis Ababa,
29-31 January 2013

2. Human BrucellosisHuman Brucellosis

3. Components of a ControlComponents of a Control
ProgramProgram
Surveillance
Vaccination
Quarantine/Removal of Infected/Risk
Reduction
Sanitation
Trained Personnel, Records,
Movement Control
Regionalization

4. SurveillanceSurveillance
Serologic testing
Sales and abbatoirs (first point testing)
Change of ownership
Interstate movement
Periodic Herd testing
i.e. Milk testing
Trained epidemiologist determines
infected versus false positives

5. Lipopolysaccharide structureLipopolysaccharide structure
of virulent and vaccine strainsof virulent and vaccine strains
Lipid A
Brucella abortus strain 19
Brucella abortus field strains
Brucella abortus strain RB51
Sugars O-side chainKDO
Lipid A KDO Sugars O-side chain
Lipid A SugarsKDO
The O-side chain is the immunodominant antigen
of Brucella for antibody responses

6. VaccinationVaccination
Approved for use by species based
on Brucella infection
May need to be regulated due to
zoonotic and abortigenic potential
Could be used as a regulatory
method to limit livestock movement

7. Thoughts on BrucellosisThoughts on Brucellosis
VaccinesVaccines
Vaccination alone will not eradicate brucellosis
Vaccines are very good at reducing
transmission and clinical disease; very poor at
preventing seroconversion after exposure
Long-term protection related to cell-mediated
immunity
Antibodies relatively unimportant for efficacy
Many vaccine strains can be pathogenic in
humans or pregnant animals

8. BrucellosisVaccines AvailableBrucellosisVaccines Available
B. melitensis: strain Rev1
(small ruminants)
B. suis: none
B. abortus strains 19 or RB51,
45/20 (cattle)
B. canis none
B. ovis none

9. Quarantine/Removal/Risk ReductionQuarantine/Removal/Risk Reduction
Quarantine is a way to isolate
infection or prevent introduction
Removal of infected animals is used
in many countries but may be cost
prohibitive
Risk Reduction – evaluate husbandry
practices to identify ways to prevent
transmission of brucellosis

10. SanitationSanitation
Segregate animals at parturition
Remove and burn afterbirth/aborted
fetuses to prevent fomite
transmission
Sanitize fluids/materials which may be
route of transmission (i.e. milk)

11. Trained Personnel/Records/AnimalTrained Personnel/Records/Animal
MovementMovement
 Use personnel with knowledge of
procedures and program
 Maintain records (vaccination, testing, etc)
to allow assessment at later times
 Infrastructure/Teamwork/Communication
 Brucellosis is usually spread by animal
movement
 Animal Identification Essential
 Control of Testing

12. Containment of Infection: Control orContainment of Infection: Control or
Eradication ProgramsEradication Programs
 Identify herd of origin and exposed
herds/flock
 Herd/flock or area plan
 Quarantine and/or depopulation
 Permanent marking of infected animals
 Sanitation: Cleaning and disinfection
 Herd testing until disease eliminated
 Vaccination as applicable
 Epidemiologic Investigations and follow
up to detection of infection

13. Control of Human BrucellosisControl of Human Brucellosis
Addressing in domestic livestock
most economical approach
- in 1 study benefit:cost ratio of 3.2 for
vaccination (Roth et al 2004)
Pasturization of milk products
Precautions taken to prevent direct
transmission

14. SummarySummary
Brucellosis control programs require
a coordinated, committed regulatory
framework
Benefits include: reduced human
disease, greater economic returns
for livestock owner, possible
improved trade opportunities

15. Comparison of Strains RB51 andComparison of Strains RB51 and
19 Vaccines in Cattle19 Vaccines in Cattle
Strain 19 Strain RB51
Serology on Standard
Brucellosis Tests
Positive;
Prolonged high titers with
booster vaccination
Negative, even on
booster vaccination
Clearance in vivo Approx. 12 weeks
Pathogenicity Moderate to High Low
Efficacy Good Similar to Strain 19
Zoonotic Characteristics Significant Human
Pathogen
Reduced Pathogenicity
as compared to strain 19
Use in Pregnant Cattle Low Dose may cause
significant abortions and
high titers
Occasional abortions